Address for submissions.

21 C.F.R. § 316.4
in effectEffective: 2024-07-01
Sign in to generate a plain English summaryAsk Belisarius Agent
All correspondence and requests for FDA action under the provisions of this rule should be addressed as follows: Office of Orphan Products Development, Food and Drug Administration, Bldg. 32, Rm. 5271, 10903 New Hampshire Ave., Silver Spring, MD 20993.

Starting a business? Corpus forms LLCs in all 50 states and DC.